Importantly, Trop2 is overexpressed in many tumor types, including pancreatic cancer, breast cancer, ovarian cancer, prostate cancer, colorectal cancer, and gastric cancer as well as squamous cell carcinoma of the oral cavity (Lombardi et al., 2023; Shen et al., 2021; Zaman et al., 2019). Here, TACSTD2 is linked to neoplasm.